Comment on: Autoimmune diseases and their prevalence in Saudi Arabian patients with type 1 diabetes mellitus

References

1. 1.↵
   1. Mohammedsaeed WM,
   2. Alghamdi ZJ.

   Autoimmune diseases and their prevalence in Saudi Arabian patients with type 1 diabetes mellitus. Saudi Med J 2023; 44: 751–760.

   OpenUrlAbstract/FREE Full Text
2. 2.
   1. McLeod DS,
   2. Cooper DS.

   The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42: 252–265.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Sumník Z,
   2. Drevínek P,
   3. Snajderová M,
   4. Kolousková S,
   5. Sedláková P,
   6. Pechová M, et al.

   HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003; 16: 851.

   OpenUrlPubMed
4. 4.↵
   1. Peterson P,
   2. Salmi H,
   3. Hyöty H,
   4. Miettinen A,
   5. Ilonen J,
   6. Reijonen H, et al.

   Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 1997; 82: 37.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. ElSayed NA,
   2. Aleppo G,
   3. Aroda VR,
   4. Bannuru RR,
   5. Brown FM,
   6. Bruemmer D.

   Standard of care of diabetes-2023. Diabetes Care 2023; 46; S19–S40

   OpenUrlCrossRef
6. 6.↵
   1. Insel RA,
   2. Dunne JL,
   3. Atkinson MA,
   4. Chiang JL,
   5. Dabelea D,
   6. Gottlieb PA, et al.

   Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015; 38: 1964.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Alotaibi A,
   2. Perry L,
   3. Gholizadeh L,
   4. Al-Ganmi A.

   Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: An overview. J Epidemiol Glob Health 2017; 7: 211–218.

   OpenUrlPubMed